NIH study identifies experimental opioid with strong pain relief and lower addiction risk

The study focuses on DFNZ, a molecule derived from a class of synthetic opioids first explored in the mid-20th century but largely abandoned due to their high potency. This research revisits nitazenes using modern pharmacological tools and aims to redesign them for greater safety. Investigators say the results represent unexpected...Read Entire Article

Apr 9, 2026 - 20:00
NIH study identifies experimental opioid with strong pain relief and lower addiction risk
The study focuses on DFNZ, a molecule derived from a class of synthetic opioids first explored in the mid-20th century but largely abandoned due to their high potency. This research revisits nitazenes using modern pharmacological tools and aims to redesign them for greater safety. Investigators say the results represent unexpected...

Read Entire Article

Jat AI Stay informed with the latest in artificial intelligence. Jat AI News Portal is your go-to source for AI trends, breakthroughs, and industry analysis. Connect with the community of technologists and business professionals shaping the future.